Clinical Trials
10 trialsNCT07046221 2025-07-20
Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT07019181 2025-06-13
Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma
The First Affiliated Hospital of Xiamen University
Phase 2 Not yet recruiting
NCT05777707 2023-03-21
Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma
Beijing Friendship Hospital
Phase 1/2 Unknown
NCT02279134 2020-04-03
Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
ChineseAMS
Phase 2/3 Unknown
NCT02858206 2019-07-26
Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma
ChineseAMS
Phase 2 Unknown
NCT03649945 2018-08-28
Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer
First Affiliated Hospital of Guangxi Medical University
Phase 2 Unknown
NCT02429622 2017-01-18
Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma
ChineseAMS
Phase 1/2 Completed
NCT02861690 2016-08-10
Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma
Sun Yat-sen University
Phase 2 Completed
NCT01175460 2012-03-06
S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer
Zhejiang Cancer Hospital
Phase 1 Completed
NCT00197444 2009-02-20
Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer
Hamamatsu University
Phase 2 Completed